Type 2 diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Daily consumption 100 grams raw red beetroot for 8 weeks.
Daily consumption 100 grams raw red beetroot for 8 weeks
Sponsors
Iran University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patient satisfaction; Diagnosis of type II diabetes (fasting blood glucose greater than or equal to 126 mg / dl or the2hpp l 200 mg / d, or random blood sugar over 200); HbA1c above 6.5% and below 8.5%; At least one year history of diabetes; TG <250 mg / dl; BMI< 35 kg / m²; Age 30 to 65 years; Patients not previously participate in any research project. Exclusion criteria: insulin injections; Hyperglycemia attacks in the past year that have led to hospitalization; Use of tobacco and alcohol; The risk of cardiovascular diseases, liver and kidney and hypothyroid; Taking antidepressants; The use of any supplemental antioxidant vitamins to 3 months; being pregnant or lacting; NSAID's use of nonsteroidol anti-inflammatory drug; The emergence of any problems or sensitivity at any time during the study; Non-adherence to treatment (less than 80% or less than 48 days); The occurrence of any patient intervention; Unwillingness to cooperate; Changing drug program (injected insulin).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HOMA-IR. Timepoint: begin and end of intervention. Method of measurement: Fasting glucose X fasting insulin formulation divided by 405.;Cognitive function. Timepoint: begin and end of intervention. Method of measurement: Rating Questionnaire.;Insulin. Timepoint: begin and end of intervention. Method of measurement: With the kit for insulin.;Hba1c. Timepoint: begin and end of intervention. Method of measurement: With the kit for Hba1c.;Fasting blood glucose. Timepoint: begin and end of intervention. Method of measurement: With the kit for FBS.;Lipid profile. Timepoint: begin and end of intervention. Method of measurement: With the kit for lipid profile.;Apo A. Timepoint: begin and end of intervention. Method of measurement: With the kit for apo A.;Apo B. Timepoint: begin and end of intervention. Method of measurement: With the kit for apo B.;Hs-CRP. Timepoint: begin and end of intervention. Method of measurement: With the kit FOR hs-CRP.;TAC. Timepoint: begin and end of intervention. Method of measurement: With the kit FOR TAC.;Homocysteine. Timepoint: begin and end of intervention. Method of measurement: With the kit for Homocysteine.;PON-1. Timepoint: begin and end of intervention. Method of measurement: With the kit for PON-1.;Nitrite. Timepoint: begin and end of intervention. Method of measurement: With the kit for nitrite. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: begin and end of intervention. Method of measurement: Weighing scale.;Blood pressure. Timepoint: begin and end of intervention. Method of measurement: Mercury Sphygmomanometer.;BMI. Timepoint: begin and end of intervention. Method of measurement: Weight in kilograms divided by the square of height in meters.;Micronutrient. Timepoint: begin and end of intervention. Method of measurement: questionnaire.;Macronutrient. Timepoint: begin and end of intervention. Method of measurement: questionnaire.;Physicsl activity. Timepoint: begin and end of intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Vafa
School of Health, Iran university of Medical Sciences
Outcome results
None listed